(R)-ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate;ethyl (R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate;Levofloxacin Impurity K;Levofloacin Impurity K;ethyl (R)-(+)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate;Levofloacin Impurity 9;Levofloxacin impurity 13/Ethyl (R)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate;Levofloxacin-11;
Levofloxacin Impurity 9 is a fully characterized chemical compound used as a reference standard of API Levofloxacin. The standard offered is compliant with regulatory guidelines. Levofloxacin Impurity 9 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 110548-06-6
Related products
Levofloxacin EP Impurity D (Levofloxacin USP Related Compound F, Defluoro Levofloxacin)
M.F.
M.W. 343.38
CAT# AR-L13548
CAS# 117620-85-6
